AMS BioteQ is dedicated to addressing antimicrobial resistance as its core mission. Through its PoroVance™ Precision Pore Engineering and Small-Molecule Drug Discovery Platform, the company has established cross-disciplinary product development capabilities.
The SIPSIP® Wound Care Series is one of the key outcomes of this technology translation strategy, integrating microenvironment management and infection control approaches into both everyday and clinical care settings, while providing scalable and standardized wound care solutions.


















